Topical BCG for recurrent superficial bladder cancer
- 6 April 1991
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 337 (8745) , 821-822
- https://doi.org/10.1016/0140-6736(91)92519-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Gene Transfer into Humans — Immunotherapy of Patients with Advanced Melanoma, Using Tumor-Infiltrating Lymphocytes Modified by Retroviral Gene TransductionNew England Journal of Medicine, 1990
- Predominant Expression of T Cell Receptor V α 7 in Tumor-Infiltrating Lymphocytes of Uveal MelanomaScience, 1990
- BIOLOGICAL SIGNIFICANCE OF BETA hCG, HLA AND OTHER MEMBRANE ANTIGEN EXPRESSION ON BLADDER TUMOURS AND THEIR RELATIONSHIP TO TUMOUR INFILTRATING LYMPHOCYTES (TIL)International Journal of Immunogenetics, 1989
- HLA—DR Expression by High Grade Superficial Bladder Cancer Treated with BCGBritish Journal of Urology, 1989
- Intravesical Evans Bacille Calmette-Guérin in the Treatment of Carcinomain situBritish Journal of Urology, 1989
- Development of Bladder Tumour Containing HPV Type 11 DNA after Renal TransplantationBritish Journal of Urology, 1988
- Does bacillus Calmette-Guérin immunotherapy accelerate growth and cause metastatic spread of second primary malignancy?Urology, 1988
- Long-term Follow-up in Patients with Superficial Bladder Tumours Treated with Intravesical EpodylBritish Journal of Urology, 1979
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969
- Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the MouseNature, 1959